News
Contact Us
Home
About Vaccinogen
Commercialization
Patents & Science
Clinical Trials
Press Kit
Science Due Diligence
Science & Technology
OncoVAX® Treatment Schedule
Scalable Production
Patent Portfolio
Science Due Diligence
Hanna, M., et al (2006) Active Specific Immunotherapy With Autologous Tumor Cell Vaccines for Stage II Colon Cancer
Vaccinogen's Investigator's Brochure Receipt Acknowledgement OncoVAX® Autologous Tumor Cells/BCG Vaccine 22 September 2009 (Edition 4.0)
OncoVAX® Technical Presentation - August 2010
Vaccinogen Overview - August 2010
Patient Handout Brochure
Vermorken, Jan B., et al (1999) Active Specific Immunotherapy for Stage II and Stage III Colon Cancer: A Randomized Trial. The Lancet 353: 345-350
Site credit:
idfive
, the interactive division of
growth5